Acutaas Chemicals Limited (ACUTAAS)
BSE
3,787.20
+20.55 (+0.55%)
Closed
Nov 6, 2026
Day's Range
3,705.003,814.35
52 wk Range
1,571.204,040.00
Financial Statements - ACUTAAS - Acutaas Chemicals Limited
Revenue
13.28B▲ 32.9%
Net Income
3.56B▲ 122.2%Net Margin 26.8%
EBITDA
5.21B▲ 109.4%
Free Cash Flow
-358.05M▲ 53.1%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Sales | 13.28B | 9.99B |
| Cost of Goods | 6.17B | 5.93B |
| Gross Profit | 7.11B | 4.06B |
 Operating Expense | - | - |
| Operating Income | 4.44B | 2.05B |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 4.82B | 2.16B |
| Income Tax | 1.26B | 557.45M |
| Net Income | 3.56B | 1.60B |
| EPS Basic | 43.51 | 19.81 |
| EPS Diluted | 43.37 | 19.81 |
| Basic Shares Outstanding | 81.87M | 80.12M |
| Diluted Shares Outstanding | 81.87M | 80.12M |
| Ebit | 4.85B | 2.22B |
| Ebitda | 5.21B | 2.48B |
| Net Income Continuous Operations | 4.82B | 2.16B |
| Minority Interests | -1.14M | -17.04M |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
